Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuting Wang
Institutions:
Southern University of Science and Technology,
Shenzhen Children's Hospital
Observed institutions:
Southern University of Science and Technology,
Shenzhen Children's Hospital
ORCID:
0000-0002-9963-5780
Observed ORCID:
0000-0002-9963-5780
OpenAlex ID:
A5134522972
Supplementary Figure S1 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S3 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S2 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S10 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S4 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S2 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S5 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S7 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S1 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S5 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S11 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S3 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Data from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S6 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S8 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S6 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S9 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Figure S4 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
Supplementary Table S7 from NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
NMB+CXCL13+CD4+ T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy
2026
·
Mingke Yu
, Lianhui Duan
, et al.
·
Cancer Immunology Research
Show more works
View as search
Works count:
20
Citation count:
H-index:
I10-index:
Year
Topic
Type